The global birth tissue products industry is on a robust growth trajectory, with a valuation of USD 2.3 billion in 2023. Driven by advancements in regenerative medicine and a growing recognition of the diverse applications of human birth tissues, the market is projected to expand at a compound annual growth rate (CAGR) of 6.6% through 2033, reaching an estimated USD 4.5 billion by the end of the forecasted period.
A recent study by Future Market Insights reveals that amniotic membrane tissue currently holds the largest share in the market, with a substantial 34.2% share as of 2022. Amniotic membrane tissue is highly valued for its unique regenerative properties, making it a key player in various therapeutic and medical applications.
The “birth tissue products industry” encompasses the utilization of human birth tissues, including the placenta and umbilical cord, for the creation of a wide range of products. These products are extensively used in both medical and cosmetic fields, leveraging their regenerative capabilities for enhanced tissue repair, wound healing, and as adjuncts in orthopedic and surgical procedures. Additionally, birth tissue products are increasingly recognized for their ability to modulate the body’s immune response, positioning them as an essential resource for developing advanced treatments for autoimmune and inflammatory diseases.
As the market continues to grow, both the medical and cosmetic industries are witnessing increased interest in the therapeutic potential of birth tissues. Innovations in regenerative medicine, along with rising awareness of the clinical benefits, are expected to further drive demand for birth tissue products in the coming years.
Key Takeaways:
- The global birth tissue products market was valued at USD 2.3 billion in 2023 and is projected to grow at a CAGR of 6.6%, reaching USD 4.5 billion by 2033.
- Amniotic membrane tissue led the market in 2022, with a share of 34.2%.
- The USA dominates the market with a 32.9% market share in 2022 and is expected to continue its growth due to the rising acceptance of regenerative medicine and increasing demand for novel treatments driven by an aging population and chronic diseases.
- In China, the market holds a 9.2% share and is growing rapidly due to the growing awareness of the benefits of birth tissue products in tissue regeneration and wound healing, as well as the affordability and accessibility of these products.
- Japan holds a 5.2% share in the global market and is experiencing growth due to the increasing demand for regenerative medicine, technological advancements in tissue engineering, and government support for the development of products for regenerative treatments.
- India‘s market share is 5.0%, with anticipated high growth driven by increasing public awareness of the healing benefits of birth tissue products and improvements in healthcare infrastructure that make these products more accessible.
Increased Market Attention: Delve into Detailed Trends and Analysis with Our Report!
Competitive Landscape:
Manufacturers of birth tissue products are increasingly focusing on differentiation through strategies such as market expansion, securing regulatory approvals for additional products, obtaining marketing approvals in new regions, and entering new geographic areas. These efforts are often complemented by partnerships with major global organizations, as well as ongoing research and development initiatives. The market dynamics have evolved due to rising awareness. For example, in November 2018, Organogenesis Inc. launched the Advanced Healing Education Resource Center, a microsite designed for continuing medical education that highlights the latest advancements in wound healing.
- In January 2023, MIMEDX entered into an exclusive distribution agreement with GUNZE MEDICAL LIMITED, a subsidiary of Gunze Limited, to promote the EPIFIX product in Japan.
Key Manufacturers and Suppliers of Birth Tissue Products:
According to FMI analysis are
- Amiox medical
- biotissue inc
- AATB
- U.S. Stem Cell Inc
- Vericel Corp. (Aastrom Biosciences Inc.)
- Organogenesis Inc. (Advanced Biohealing)
- Cerapedics Inc
- Mesoblast Ltd.
- Ocata Therapeutics Inc. (Astellas Pharma Inc.)
- Tissue Recover(Alpha Cord)
- BTR(Birth Tissue recovery)LLC
- Tellagen llc
- Predictive biotech
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
Key Market Segments Covered in the Birth Tissue Products Industry Research:
Tissue:
- Placenta
- Amniotic Membrane
- Chorionic Membrane
- Amniotic Fluid
- Umbilical Cord Tissue
- Umbilical Veins
- Wharton’s Jelly
Application:
- Cardiovascular Disorders
- Oncology
- Dermatology
- Musculoskeletal
- Wound Care
- Ophthalmology
End User:
- Hospitals
- Birth Centers
- Academic & Research Institutes
Region:
- North America
- Latin America
- East Asia
- South Asia & Pacific
- Western Europe
- Eastern Europe
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube